← FDA DRUG APPROVALS

FDA ANDA · ANDA061910

ILOTYCIN

Sponsor: DISTA

APPLICATION
ANDA061910
TYPE
ANDA
ORIGINAL APPROVAL
1975-02-27
LATEST ACTION
1992-01-31
ROUTE
ORAL
DOSAGE FORM
TABLET, DELAYED RELEASE
MARKETING STATUS
Discontinued

Products

ILOTYCINDiscontinued
ERYTHROMYCIN 250MG · TABLET, DELAYED RELEASE · ORAL

Approval history

1992-01-31Labeling · Supplement 4AP
1991-09-05Labeling · Supplement 5AP
1991-09-05Labeling · Supplement 6AP
1990-04-10Manufacturing (CMC) · Supplement 3AP
1975-02-27OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →